Cost-effectiveness of prostate cancer screening: a systematic review of decision-analytical models.

ABSTRACT:

Background

There is ongoing debate about the harms and benefits of a national prostate cancer screening programme. Several model-based cost-effectiveness analyses have been developed to determine whether the benefits of prostate cancer screening outweigh the costs and harms caused by over-detection and over-treatment, and the different approaches may impact results.

Methods

To identify models of prostate cancer used to assess the cost-effectiveness of prostate cancer screening strategies, a systematic review of articles published since 2006 was conducted using the NHS Economic Evaluation Database, Medline, EMBASE and HTA databases. The NICE website, UK National Screening website, reference lists from relevant studies were also searched and experts contacted. Key model featur

SUBMITTER: Sanghera S 

PROVIDER: S-EPMC5773135 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature